Trial intelligence / Profile preview

Efficacy of ACB vs ACB+IPACK after knee replacement surgery

DRKS00023090Phase 4Recruiting

Sponsor
Hospital of Traumatology and Orthopaedics
Start
Sep 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain and knee osteoarthritis (OA) (2 arms), sponsored by Hospital of Traumatology and Orthopaedics. Started Sep 2020; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative painknee osteoarthritis (OA)

Beyond the preview

Go deeper on DRKS00023090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00023090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call